Clonidine: irritant and allergic contact dermatitis assays
- 11 April 1985
- journal article
- research article
- Published by Wiley in Contact Dermatitis
- Vol. 12 (4), 192-195
- https://doi.org/10.1111/j.1600-0536.1985.tb01104.x
Abstract
Clonidine in petrolatum, clonidine transdermal device, and its placebo device were assayed for relative irritancy potential (21‐day cumulative irritancy, assay)and allergic contact dermatitis potential (Draize repeal insult patch test assay). Both Clonidine in petrolatum and the Clonidine transdermal device appear to be of minimal irritancy potential. Only the clonidine device demonstrated, rated, in the Draize assay (and in clinical trials), allergic contact dermatitis potential. Its relatively delayed onset of demonstration of allergic contact sensitization in clinical trials require investigation as to mechanism.Keywords
This publication has 8 references indexed in Scilit:
- Clonidine Transdermal Delivery System: Cutaneous Toxicity StudiesPublished by Springer Nature ,1985
- Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal systemAmerican Heart Journal, 1984
- Rationale for rate-controlled drug delivery of cardiovascular drugs by the transdermal routeAmerican Heart Journal, 1984
- Transdermal administration of clonidine for treatment of high BPArchives of Internal Medicine, 1984
- ALLERGIC CONTACT DERMATITIS WITH TRANSDERMAL CLONIDINEThe Lancet, 1983
- ALLERGIC SKIN REACTIONS TO TRANSDERMAL CLONIDINEThe Lancet, 1983